Knowledge & experience
- Staff member, Solid Tumor Department, Princess Máxima Center, Utrecht
- 2019 – 2024 PhD research, PI Professor Dr. J.H.M. Merks, Princess Máxima Center, Utrecht
- 2019 – 2024 Pediatric oncology fellowship, Princess Máxima Center, Utrecht
- 2018 – present Instructor, Acute Pediatric Life Support (APLS), SSHK, Riel
- 2018 – 2019 Chief of clinic, Stem Cell Transplantation Department, Princess Máxima Center, Utrecht
- 2013 – 2018 Pediatric residency, Emma Children's Hospital – AMC, Amsterdam
Scientific research
You can read my publications on PubMed here.
Selected articles
- Biological sample collection to advance research and treatment: a Fight Osteosarcoma Through European Research (FOSTER) and Euro Ewing Consortium (EEC) statement
- A systematic review of recent phase-II trials in refractory or recurrent osteosarcoma: Can we inform future trial design?
- European standard clinical practice recommendations for children and adolescents with primary and recurrent osteosarcoma
- Quantitative diffusion-weighted MRI response assessment in rhabdomyosarcoma: an international retrospective study on behalf of the European paediatric Soft tissue sarcoma Study Group Imaging Committee
- International Soft Tissue saRcoma ConsorTium (INSTRuCT) consensus statement: Imaging recommendations for the management of rhabdomyosarcoma.
- European guideline for imaging in paediatric and adolescent rhabdomyosarcoma - joint statement by the European Paediatric Soft Tissue Sarcoma Study Group, the Cooperative Weichteilsarkom Studiengruppe and the Oncology Task Force of the European Society of Paediatric Radiology
- The Value of Early Tumor Size Response to Chemotherapy in Pediatric Rhabdomyosarcoma.
- High-dose chemotherapy followed by autologous haematopoietic cell transplantation for children, adolescents, and young adults with primary metastatic Ewing sarcoma.
- High-dose chemotherapy followed by autologous haematopoietic cell transplantation for children, adolescents, and young adults with first recurrence of Ewing sarcoma.
BIG registration
59913591101
Contact
Phone 088 972 72 72